Literature DB >> 6090715

Results of six hundred thirty-six esophageal transections with paraesophagogastric devascularization in the treatment of esophageal varices.

M Sugiura, S Futagawa.   

Abstract

This report describes 636 patients with portal hypertension in whom esophageal transections with paraesophagogastric devascularization were performed for the management of esophageal varices. The procedure was a prophylactic measure in 185 patients, elective surgery in 349, and an emergency procedure in 102. Portal hypertension was due to cirrhosis of the liver in 464 patients (40 alcoholic and 424 cryptogenic), idiopathic portal hypertension in 99, extrahepatic portal vein occlusion in 38, hepatoma in 22, and other causes in 13. The operative mortality rates were as follows: emergency 13.7%, elective cases 3.2%, prophylactic cases 4.3%, and overall 5.2%. There were no deaths in the 233 patients in Child's clinical class A; 232 class B patients had a 2% mortality rate, and 171 class C patients had a 17% mortality rate. The 10-year actuarial survival rates in patients with cirrhosis of the liver were 55% in emergency cases and 72% in both prophylactic and elective cases. In patients without cirrhosis the survival rates were 90%, 96%, and 95%, respectively. Recurrence of variceal bleeding or varices was less than 5%. We conclude that the Sugiura procedure is safe and effective in controlling esophageal varices and prolongs the long-term survival of patients with portal hypertension.

Entities:  

Mesh:

Year:  1984        PMID: 6090715

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  16 in total

1.  Transabdominal gastro-esophageal devascularization and esophageal transection for bleeding esophageal varices after failed injection sclerotherapy: long-term follow-up report.

Authors:  Shabir Ahmad Qazi; Kamran Khalid; Abdul Majeed Abdul Hameed; Khalid Al-Wahabi; Radwan Galul; Saleh M Al-Salamah
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  76th General Meeting of the Japanese Society of Gastroenterology. Tokyo, Japan, March 29-31, 1990. Abstracts.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1992-02

Review 3.  The use of sclerotherapy for the management of oesophageal varices in portal hypertension.

Authors:  J Terblanche
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

Review 4.  Gastric venous reconstruction after radical pancreatic surgery: case report and review of the literature.

Authors:  Charbel Sandroussi; Ian D McGilvray
Journal:  J Gastrointest Surg       Date:  2010-04-13       Impact factor: 3.452

Review 5.  Long-term management of variceal bleeding: the place of varix injection and ligation.

Authors:  J Terblanche; G V Stiegmann; J E Krige; P C Bornman
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

6.  Liver transplantation in the treatment of bleeding esophageal varices.

Authors:  S Iwatsuki; T E Starzl; S Todo; R D Gordon; A G Tzakis; J W Marsh; L Makowka; B Koneru; A Stieber; G Klintmalm
Journal:  Surgery       Date:  1988-10       Impact factor: 3.982

7.  Factors affecting immediate and long-term survival after emergent and elective splanchnic-systemic shunts.

Authors:  J G Chandler; C H Van Meter; D L Kaiser; S E Mills
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

Review 8.  Portal hypertension management.

Authors:  J Terblanche
Journal:  Surg Endosc       Date:  1993 Nov-Dec       Impact factor: 4.584

9.  Extrahepatic portal hypertension in children: observations on three surgical procedures.

Authors:  K L N Rao; Anju Goyal; Prema Menon; B R Thapa; K L Narasimhan; S K Chowdhary; R Samujh; J K Mahajan
Journal:  Pediatr Surg Int       Date:  2004-09-04       Impact factor: 1.827

10.  A prospective trial of endoscopic sclerotherapy v oesophageal transection and gastric devascularisation in the long term management of bleeding oesophageal varices.

Authors:  D R Triger; A G Johnson; J E Brazier; G W Johnston; E F Spencer; R McKee; J R Anderson; D C Carter
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.